Track topics on Twitter Track topics that are important to you
The one-stop-shop for cGMP-compliant Manufacturing, Fill & Finish of Antigens, Bacteria, Viruses and Vaccines.
Our Philosophy is to be "Transparent with your Time and Money".
• Extensive experience with cell-line and process development for manufacturing of proteins, fusion constructs and “recombinant” viruses
• Production of your biologicals of interest in a variety of bacterial or mammalian hosts
• Analytical method development
• Major US and EU Pharmaceutical companies as references
• Formulation and filling, including viruses in a cGMP compliant BL2 facility.
• Top class cGMP facility
• Bio-Safety-Level 2 section
• Designed and equipped to facilitate customized production needs
• The right Team for your request, in your Time-Frame
• Streamlined follow-through for on-time delivery
• Part of Solvay Pharmaceuticals
• Validation according to ICH guidelines
• Development and qualification of a widespread range of analytical methods
• Independent QC team for IPC and release testing
• Independent QA team with QP
Phone: 32 9 329 1200
Australia’s drug regulatory agency, the Therapeutic Goods Administration (TGA), announced on 28 July 2017 that it was opening a consultation on how to name biologicals.
In the European Union (EU), decisions on the interchangeability or substitution of biosimilars and originator biologicals are not made by the European Medicines Agency (EMA), but at the national level...
Inflammatory bowel disease (IBD) is mainly characterized by two chronic, relapsing, immune-mediated inflammatory diseases of the gastrointestinal tract: Crohn’s disease and ulcerative colitis. Appro...
ANKENY, Iowa and FEILDING, New Zealand, July 17, 2017 /PRNewswire/ -- Following a recent Chinese decision, centered around New Zealand Origin Bovine Material, Proliant Biologicals is now eligible to s...
SummaryBased on products type, the report describes major products type share of regional market. Products mentioned as follows: By Standard USDA Standards European Standards OthersBased on ...
Competition between brand-name biologicals and biosimilars has the potential to reduce future cancer costs, according to researchers from Italy .
A self-sampling method for therapeutic drug monitoring (TDM) of biologicals was developed that should enhance TDM implementation by patients with...
The US Food and Drug Administration (FDA) received 52 comments on its draft guidance on the interchangeability of biosimilars with their reference biologicals.
Albumin (Human) U.S.P. Human Albumin Grifols 20%
Albumin (Human) U.S.P. Human Albumin Grifols 25%
These highlights do not include all the information needed to use Albutein 5% safely and effectively. See full prescribing information for Albutein 5%. Albutein 5% [Albumin (Human) U.S.P.] sterile, aq...
These highlights do not include all the information needed to use Albutein 20% safely and effectively. See full prescribing information for Albutein 20%. Albutein 20% [Albumin (Human) U.S.P.] sterile,...
These highlights do not include all the information needed to use Albutein 25% safely and effectively. See full prescribing information for Albutein 25%.Albutein 25% [Albumin (Human) U.S.P.] sterile, ...
Treatment satisfaction can be improved by integrating patients' preferences into shared decision-making. We recently investigated patients' preferences for attributes of biologicals, and showed high p...
Biologicals provide a tight disease control but not all patients respond favourably to treatment. Some patients do not respond at all (primary non-responders), while other patients respond initially b...
The purpose of this observer-blind study is to generate immunogenicity data with one formulation of GSK Biologicals' DTPw-HBV/Hib vaccine after the primary vaccination course and to demons...
The purpose of this study is to show that vaccination with a single dose of GSK Biologicals' pandemic H1N1 vaccine results in an immune response that meets or exceeds European Medicines Ag...
The purpose of this Phase II study is to evaluate the feasibility of GSK Biologicals' GSK2197870A vaccine co-administered with Wyeth-Lederle's Prevenar™ when given in healthy infants as ...
The purpose of this study is to evaluate the safety and immunogenicity of 2 formulations of GSK Biologicals' varicella vaccines given as a 2-dose course in the second year of life.
This study will evaluate the safety and immunogenicity of GSK Biologicals' GSK2202083A vaccine co-administered with GSK Biologicals' 10-valent pneumococcal conjugate (GSK1024850A) vaccine ...
The mission of Novus Biologicals, Inc. is to accelerate scientific discovery by marketing unique products in the forefront of science. Novus Biologicals was organized to provide the biological researc...
Our mission at Novus Biologicals, Inc. is to supply monoclonal and polyclonal antibodies, recombinant protein and cDNAs for the scientific research community that are of high quality and applicability...
Affinity Biologicals Inc. (ABI) is now in it’s sixteenth year as a manufacturer of antibodies and antibody-related products for use in thrombosis and haemostasis research as well as medical diagnost...
Affinity Biologicals Inc. is a manufacturer producing antibodies and antibody-related reagents and plasmas used in thrombosis and hemostasis research and in medical diagnostics manufacturing. A primar...
Since 1911, Pel-Freez has been committed to providing cost-effective, quality products. Today, Pel-Freez Biologicals manufactures quality animal biologicals for life science research and in vitro diag...
We have published hundreds of Innogenetics Biologicals news stories on BioPortfolio along with dozens of Innogenetics Biologicals Clinical Trials and PubMed Articles about Innogenetics Biologicals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Innogenetics Biologicals Companies in our database. You can also find out about relevant Innogenetics Biologicals Drugs and Medications on this site too.